OGB-21502

N/A

Report date: 2026/04/07 20:00:20

Base Information

Drug NameOGB-21502
Drug Alias NameOGB-21502OGB21502
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionFibroblast growth factor 21 agonistsGlucagon-like peptide 1 receptor agonistsGlucagon receptor agonists +[4] 
TargetsFibroblast growth factor 21Glucagon-like peptide 1 receptorGlucagon receptor +[4] 
Therapy Area/IndicationsObesityPulmonary FibrosisLiver Cirrhosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOnegene Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesOnegene Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsObesityPulmonary FibrosisLiver Cirrhosis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A